Navigation Links
ShangPharma Announces Second Quarter 2012 Results
Date:8/20/2012

SHANGHAI, Aug. 20, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudited financial results for the second quarter ended June 30, 2012.

Second Quarter 2012 Highlights

  • Net revenues increased by 15.7% year-over-year to $31.8 million.
  • Net revenues from the Company's top-10 customers increased by 21.3% year-over-year to $20.6 million, representing approximately 64.8% of total net revenues.
  • Net revenues from full-time-equivalent ("FTE")-based services increased by 21.0% year-over-year to $23.9 million.
  • GAAP gross margin was 27.8%, compared with 33.3% in the second quarter of 2011. Non-GAAP gross margin was 29.0%, compared with 34.7% in the second quarter of 2011.
  • GAAP operating margin was 2.4%, compared with 10.3% in the second quarter of 2011. Non-GAAP operating margin was 7.6% compared with 15.2% in the second quarter of 2011.
  • Management Comment"I am pleased to report that during a challenging second quarter, ShangPharma made excellent progress on several key strategic goals, including increasing revenue from biologics and shifting more of our work to FTE-based services," said Michael Xin Hui, founder and Chief Executive Officer of ShangPharma. "It is a testament to the strength of our offering that global leading pharmaceutical and biotech companies continued to expand their relationships with us."

    Mr. Hui continued, "Our previously discussed investments helped us to win additional business, but also placed pressure on our margins this quarter. The increased competition that we saw in more mature service offerings in the second quarter strengthened our confidence in our long-term strategy to invest in capabilities, facilities and staff, allowing
    '/>"/>

    SOURCE ShangPharma Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. ShangPharma Corporation Files 2011 Annual Report on Form 20-F
    2. ShangPharma to Report First Quarter 2012 Financial Results on May 17, 2012
    3. ShangPharma Announces First Quarter 2012 Results
    4. ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS
    5. ShangPharma Independent Committee Appoints Chairman and Legal Counsel
    6. ShangPharma Independent Committee Appoints Financial Advisor
    7. ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012
    8. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
    9. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
    10. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
    11. Misonix Announces New Distribution Agreement For Panama
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/23/2015)... 2015  AbbVie (NYSE: ABBV ) has announced ... accepted its New Drug Application (NDA) and granted priority ... treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV). ... chronic genotype 4 (GT4) hepatitis C virus (HCV) infection. ... therapy being evaluated by the FDA for patients in ...
    (Date:4/23/2015)... April 23, 2015 /CNW/ - Health Canada is working ... to update the safety information regarding the risk of ... when these products are used at high doses (at ... and duration of use. Ibuprofen is a ... relief, and to reduce inflammation. The majority of ibuprofen ...
    (Date:4/23/2015)... Surna, Inc. (OTCQB: SRNA), a technology company ... and systems for controlled environment agriculture ("CEA") with ... host a shareholder conference call to discuss its ... PM Eastern Standard Time/1:15 PM Pacific Standard Time. ... listen-in only, but will include a Q&A session ...
    Breaking Medicine Technology:U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 2Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 3Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 4Surna, Inc. Announces Shareholder Conference Call 2Surna, Inc. Announces Shareholder Conference Call 3
    ... BEIJING , July 15 /PRNewswire-Asia/ -- Sinovac Biotech ... China , announced today that it,held its 2010 Annual Meeting of ... Beijing Time. The required quorum, a majority of the ... was held,concurrently at No. 39 Shangdi Xi Road, Haidian District, ...
    ... SUNNYVALE, Calif. , July 15 Premier ... and 67,000-plus other healthcare sites working together to achieve ... provider of FDA-cleared Electronic Brachytherapy Systems, announced the execution ... exclusive three-year contract for brachytherapy systems with Premier Purchasing ...
    Cached Medicine Technology:Sinovac Holds 2010 Annual Meeting of Shareholders 2Xoft Announces Exclusive Contract With Premier for Electronic Brachytherapy 2Xoft Announces Exclusive Contract With Premier for Electronic Brachytherapy 3
    (Date:4/25/2015)... The Hon. Ellen Tauscher, Independent Chair ... following statement following the deadly earthquake in Nepal: , ... in the deaths of more than 1,000 people. ... Nepal, Bangladesh, India and other parts of South Asia. ... the people of Nepal and the families of the ...
    (Date:4/25/2015)... (PRWEB) April 25, 2015 Carinsurancequotesinfo.com has ... find low cost auto insurance for flatbed ... heavy goods and sometimes other vehicles. They are mainly ... insurance. The newly released blog post explains that by ... for trucks, vans and other commercial vehicles. , It ...
    (Date:4/25/2015)... Caicos Islands, BWI (PRWEB) April 25, 2015 ... (PLS) has celebrated three months of successfully welcoming visitors ... January 5, 2015. , As part of a ... of Providenciales airport was completely redesigned to speed up ... up the process of getting out of the airport ...
    (Date:4/25/2015)... York (PRWEB) April 25, 2015 The URO ... Jerry Blaivas has been chosen by the New York Academy ... contributions to medicine in the field of Urology. , Dr. ... in his speciality, Genito-Urinary diseases. He was a man ... the field of urology. Not only did he devote ...
    (Date:4/25/2015)... Minnesota (PRWEB) April 25, 2015 For thirteen ... the premier income protection education event in the nation! This ... with The Plus Group, US to take DI Day on ... , George G. Davidson, CLU, ChFC, RHU, DIA, CLTC, Chief ... Cities DI Day reflects on the change by stating, "The ...
    Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2Health News:The Tuscany on Grace Bay Celebrates Providenciales Airport Expansion With Summer Specials to Travelers! 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Secura Consultants Takes DI Day On The Road 2
    ... attention of the entire world appears to be focused on the ... globe. AIDS which has already taken a toll of 25 million ... same level of attention. The AIDS program does not even have ... ,The areas that are worst affected by AIDS are mostly ...
    ... beneficial effects of physical activities such as running, jogging on ... has now been found by neuroscientists from Germany that running ... boost of memory. // ,The study ... sessions per week followed by which they had to take ...
    ... Vietnamese patients who were infected with the H5N1 bird flu ... Roche drug, Tamiflu. The virus appears to have developed a ... among medical circles. The virus was seen to mutate in ... 274Y resistant strains were seen in both cases. ...
    ... study conducted at the University of Texas has revealed ... to develop heart problems compared to their counterparts. // ... be afflicted with the disease worldwide with approximately 10 ... many factors that contribute to this disease including age, ...
    ... treatment now offers hope for treatment of Ambylopia or lazy eye ... the combined efforts of researchers at the USC and three other ... normal, although there may a compromise in the vision even when ... vision loss. Until now, the condition has been regarded to be ...
    ... launched by the pharmaceutical company Pfizer in 30 different cities ... to suffer from erectile dysfunction.// The drug company is expected ... the market within the next two years according to K.G. ... Indian wing. ,Several factors regarding the Indian Pharmaceutical ...
    Cached Medicine News:Health News:Flu Pandemic Gets More Attention Than AIDS 2Health News:Erectile Dysfunction Drug Viagra Launched In India By Pfizer 2
    ... System is a single-use, disposable needle loading ... into a Bard BrachyStar needle for interstitial ... radiation safety shield, inner compartment that holds ... fitting that connects the cartridge to the ...
    ... Holter Monitoring System uses technology developed by ... first true 12-lead digital Holter recorder in ... beat contained in the 24-hour study provides ... work done by the Q-12 digital recorder ...
    Data review and analysis is carried out with the Acquidata Uromac software already supplied with Acquidata Uromac Lab based urodynamics systems...
    ... any clinical setting, offering an exclusive ... procedure. Customize Delphis™ to your exact ... Pocket PC, a Touchpad PC Tablet ... technology allows you to focus on ...
    Medicine Products: